Committee on Leading Health Indicators for Healthy People 2010 & Institute of Medicine 
Leading Health Indicators for Healthy People 2010 [PDF ebook] 
First Interim Report

Hyperthermia in oncology is the application of heat to a patient »s body for the purpose of cancer treatment. In recent years, its use has seen rapid development, with a large amount of clinical data …

The study of areas in the cerebral cortex has a long history, bringing empirical data into close relation with fundamental conceptual issues about the cortex. The subject is currently being revitaliz …

Imaging Drug Action in the Brain is an outstanding reference that provides detailed methodological information and presents a current review of information obtained using various methods to delineate …

Providing a general approach to the understanding and management of all forms of chronic pain, this book offers a clear and reader-friendly format that clarifies procedures in the diagnosis, assessme …

Assistive technology has made it feasible for individuals with a wide range of impairments to engage in many activities, such as education and employment, in ways not previously possible. The key fac …

Magnetic resonance imaging (MRI) is a rapidly developing field in basic applied science and clinical practice. Research efforts in this area have already been recognized with five Nobel prizes awarde …

Hip Replacement offers useful strategies to

choose the appropriate biomaterials and implant structure

avoid complications in hip replacement surgery

analyze the bone-biomateri …

Curing Physician Management Why Physician Managers Fail Curing Physician Management: Why Physician Managers Fail is written for physicians who are in or taking on a management role in healthcare, and …

This book focuses on analytical similarity assessment in biosimilar product development following the FDA’s recommended stepwise approach for obtaining totality-of-the-evidence for approval of biosim …

Methodologies for Biosimilar Product Development covers the practical and challenging issues that are commonly encountered during the development, review, and approval of a proposed biosimilar produc …